Leronlimab P2 study improves the most common sympt

Leronlimab P2 study improves the most common symptoms for Covid19 long haulers. IMO the Leronlimab results that correlate to the ranked symptom list below are marked by an asterisk. See the Cytodyn press releases as well as other links at the bottom.

*Fatigue
*Muscle or body aches
*Shortness of breath or difficulty breathing
*Difficulty concentrating or focusing
*Inability to exercise or be active
*Headache
*Difficulty sleeping
Anxiety
Memory problems
*Dizziness
*Persistent chest pain or pressure
*Cough
*Joint pain
*Heart palpitations
Diarrhea
Sore throat
Night sweats
*Partial or complete loss of sense of smell
*Tachycardia
*Fever or chills
Hair loss
Blurry vision
*Congested or runny nose
Sadness
*Neuropathy in feet and hands
Reflux or heartburn
Changing symptoms
*Partial or complete loss of sense of taste


https://static1.squarespace.com/static/5e8b5f...5.4%29.pdf

https://www.medrxiv.org/content/10.1101/2021....2.full.pdf

https://www.cytodyn.com/newsroom/press-releas...results-of

https://www.cytodyn.com/newsroom/press-releas...-unblinded

There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.